Longtime tax partner at Baker McKenzie has made the jump to Jones Day, joining the firm’s Sydney office.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
Aristocrat has sued competitor Light & Wonder and two former employees for allegedly using confidential information about its popular Dragon Link poker game to develop a competing product.
Gaming giant Aristocrat has defeated a challenge by Light & Wonder to discovery orders it won for a possible lawsuit alleging two former employees who jumped ship to its rival misused confidential information about its popular Lightning Link and Dragon Link games.
Jones Day has bolstered its financial markets practice with the addition of a former Baker McKenzie special counsel.
A judge has rejected Aristocrat’s bid for orders requiring competitor Light & Wonder to hand over documents to be placed “in an envelope” for speedy production should its appeal of a decision ordering that it produce the documents to Aristocrat for possible trade secrets suit fail.
South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.
Game maker Light & Wonder is fighting orders requiring it to hand over information to Aristocrat Gaming for a possible suit alleging it and two former employees who jumped ship misused confidential information about Aristocrat’s popular Lightning Link and Dragon Link games.
Casino gaming giant Aristocrat may sue competitor Light & Wonder and two former employees who jumped ship for allegedly misusing confidential information about its popular Lightning Link and Dragon Link games to develop a competing product.